Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations-Reference-Cited by-同舟云学术

Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations

Published:2024-03-12 Issue:5 Volume:102 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Salter Amber¹^ORCID,Lancia Samantha¹,Kowalec Kaarina¹^ORCID,Fitzgerald Kathryn C.¹^ORCID,Marrie Ruth Ann¹^ORCID

Affiliation:

1. From the Department of Neurology (A.S., S.L.), Section on Statistical Planning and Analysis, UT Southwestern Medical Center, Dallas, TX; College of Pharmacy (K.K.), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Department of Medical Epidemiology and Biostatistics (K.K.), Karolinska Institutet, Sweden; Department of Neurology (K.C.F.), Johns Hopkins School of Medicine, Baltimore, MD; and Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000209135

Reference40 articles.

1. Causes and consequences of comorbidity

2. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview

3. Sex differences in comorbidity at diagnosis of multiple sclerosis

4. Food and Drug Administration. Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. Silver Spring, MD; 2020. Accessed December 20, 2020. fda.gov/regulatory-information/search-fda-guidance-documents/enhancing-diversity-clinical-trial-populations-eligibility-criteria-enrollment-practices-and-trial

5. The challenge of comorbidity in clinical trials for multiple sclerosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Author Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations;Neurology;2024-10-22

2. Reader Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations;Neurology;2024-10-22

3. Assessing disease progression and treatment response in progressive multiple sclerosis;Nature Reviews Neurology;2024-09-09

4. Depression and anxiety in multiple sclerosis. Review of a fatal combination;Journal of Neural Transmission;2024-06-13